A search for “GLP1 near me” can return medical practices, wellness clinics, telehealth services, and pharmacies. They are not all offering the same type of care. The useful question is whether a service provides a valid clinical evaluation, uses licensed professionals and pharmacies, explains the product clearly, and stays available after the first visit.
Important safety information for FDA-approved branded medicines. Ozempic and Wegovy contain semaglutide and are FDA-approved prescription medicines from Novo Nordisk A/S. Mounjaro and Zepbound contain tirzepatide and are FDA-approved prescription medicines from Eli Lilly and Company. These products carry a boxed warning for the risk of thyroid C-cell tumors. They are contraindicated for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Serious risks can include pancreatitis, gallbladder disease, acute kidney injury, severe stomach problems, serious allergic reactions, low blood sugar with certain diabetes medicines, and diabetic retinopathy complications. Read the official Prescribing Information and Medication Guides for Ozempic, Wegovy, Mounjaro, and Zepbound.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
Know what GLP-1 means
GLP-1 refers to glucagon-like peptide-1, a hormone involved in blood sugar regulation, appetite, and digestion. Prescription medicines in this area do not all contain the same ingredient or have the same approved use. Some act on the GLP-1 receptor, while tirzepatide acts on both GIP and GLP-1 receptors.
That distinction is one reason a broad online search cannot choose a medicine for you. A clinician needs to review your medical history and the official labeling for the specific product being considered. The FDA-approved label, not an advertisement or social media post, is the reliable source for approved uses and safety information.
Verify the clinician
A legitimate visit begins with a licensed clinician. Look up the clinician through the licensing board for the state where you will be located during care. Confirm that the license is active and belongs to the person evaluating you.
Expect questions about current medicines, allergies, medical history, prior treatment, and relevant risks. The clinician may need records or testing. The evaluation should allow for the answer that a prescription is not appropriate.
Ask who will provide follow-up, how to report side effects, and how quickly urgent questions are routed. A one-time encounter without a clear contact path may not provide the continuing support you expect.
Verify the pharmacy
Any pharmacy dispensing to you should be licensed to serve your state. A local storefront may be convenient, but a properly licensed mail-order pharmacy may also be an option. Search the state board of pharmacy’s records and use FDA’s BeSafeRx resources when reviewing an online pharmacy.
Ask the care service to identify the dispensing pharmacy before you agree to treatment. A website that will not name the pharmacy, offers prescription medicine without a prescription, or substitutes an unclear product deserves additional scrutiny.
FDA-approved branded options
FDA approval applies to a specific finished product for the uses and conditions in its label. It does not mean every medicine in the class is approved for every purpose or every person. A clinician weighs the labeled indications, contraindications, warnings, interactions, and patient history before deciding whether to prescribe.
If insurance is involved, check the exact drug and use with the plan. Formularies, prior authorization requirements, deductibles, and preferred pharmacies may affect payment. The plan makes coverage and payment decisions. No clinic can promise that a request will be approved.
Coverage support can include checking benefits, helping gather information, and submitting paperwork requested by the plan. It is assistance, not control over the insurer’s decision.
Compounded options are different
Compounded semaglutide and compounded tirzepatide are pharmacy-prepared medications. They are not FDA-approved finished drug products and must remain clearly separate from the branded options above.
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or manufacturing quality.
Compounded semaglutide and compounded tirzepatide are not Zepbound, Mounjaro, Ozempic, or Wegovy. They are not generic versions of approved drugs and are not interchangeable with them. No comparison should imply the same quality, safety, effectiveness, or regulatory status.
A compounded medication may be dispensed only pursuant to a valid prescription issued by a licensed clinician after a clinical evaluation, from a state-licensed pharmacy. The clinician determines whether it is appropriate for a particular patient. FDA’s overview of human drug compounding explains that compounded drugs do not undergo FDA premarket review.
If a compounded medication is discussed, ask for its active ingredient, dosage form, dispensing pharmacy, and directions on the prescription. Do not rely on a nickname that makes the product’s identity unclear.
Understand the complete care relationship
Good care continues after a prescription decision. Ask about follow-up visits, refills, side-effect support, medication changes, and the process for contacting the clinical team. Also ask what happens when laboratory work or an in-person evaluation becomes appropriate.
Never start, stop, share, or change the dose of a prescription based on general online information. Contact the prescribing clinician or pharmacist for instructions. Seek urgent care when symptoms may be severe.
Keep each cost on its own line
A service fee can cover clinical evaluation and support. A pharmacy charge pays for medication. Laboratory work, delivery, or supplies may create other charges. Request a written breakdown so an advertised amount is not mistaken for the total cost of care.
Body Good’s prices are Body Good service fees for the program described at intake, not prices for medication and not a quote for any individual. Eligibility is determined by a clinician. Medication cost is separate and is not included in the service fee. Clinically appropriate outside laboratory work may also cost extra.
Body Good can provide coverage support by helping check benefits and prepare information requested by a plan. The plan determines approval and payment. Body Good does not guarantee coverage.
This website provides information and a pricing overview only. It does not take payment, collect protected health information, or host an intake form. Intake takes place on joinbodygood.com.
Frequently asked questions
Is telehealth considered care near me?
It can be. What matters is that the clinician is properly licensed for your location and the pharmacy is licensed to dispense in your state. Telehealth can reduce travel, but it does not remove clinical or licensing requirements.
How do I know whether a product is compounded?
Ask the clinician and pharmacy directly, and read the prescription and dispensing label. A compounded medication should be identified by its active ingredient and should not be presented as a generic or interchangeable version of an approved drug.
What is the next step with Body Good?
A clinical review comes before any prescribing decision. Begin Body Good’s secure clinical intake to provide information for a licensed clinician.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.